Teva Pharmaceutical Industries (TEVA) Finished Goods (2010 - 2018)
Teva Pharmaceutical Industries' (TEVA) quarterly Finished Goods came in at $2.7 billion in Q4 2018, down 0.89% YoY from $2.7 billion in Q4 2017, and down 0.52% on a QoQ basis from $2.7 billion in Q3 2018.
Teva Pharmaceutical Industries (TEVA) Finished Goods (2010 - 2018) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has 9 years of Finished Goods data on file, last reported at $2.7 billion in Q4 2018.
- Quarterly Finished Goods fell 0.89% year-over-year to $2.7 billion in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $2.7 billion (down 0.89% YoY) and the FY2018 annual result came in at $2.7 billion, down 0.89% from the prior year.
- Finished Goods eased to $2.7 billion in Q4 2018, from $2.7 billion in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $2.9 billion in Q2 2017 to a low of $2.0 billion in Q1 2016.
- A 5-year average of $2.5 billion and a median of $2.6 billion in 2014 frame the typical range for Finished Goods.
- Annual changes were most pronounced in 2015 — Finished Goods retreated 16.08% — and 2017, when it surged 43.01%.
- Tracing TEVA's Finished Goods over 5 years: stood at $2.3 billion in 2014, then retreated by 9.61% to $2.1 billion in 2015, then soared by 38.15% to $2.8 billion in 2016, then fell by 5.05% to $2.7 billion in 2017, then retreated by 0.89% to $2.7 billion in 2018.
- The last three Finished Goods figures came in at $2.7 billion (Q4 2018), $2.7 billion (Q3 2018), and $2.7 billion (Q2 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 2.67 Bn |
| Sep 30, 2018 | 2.68 Bn |
| Jun 30, 2018 | 2.71 Bn |
| Mar 31, 2018 | 2.77 Bn |
| Dec 31, 2017 | 2.69 Bn |
| Sep 30, 2017 | 2.75 Bn |
| Jun 30, 2017 | 2.89 Bn |
| Mar 31, 2017 | 2.87 Bn |
| Dec 31, 2016 | 2.83 Bn |
| Sep 30, 2016 | 2.83 Bn |
| Jun 30, 2016 | 2.02 Bn |
| Mar 31, 2016 | 2.01 Bn |
| Dec 31, 2015 | 2.05 Bn |
| Sep 30, 2015 | 2.10 Bn |
| Jun 30, 2015 | 2.19 Bn |
| Mar 31, 2015 | 2.14 Bn |
| Dec 31, 2014 | 2.27 Bn |
| Sep 30, 2014 | 2.36 Bn |
| Jun 30, 2014 | 2.50 Bn |
| Mar 31, 2014 | 2.55 Bn |